# Dehydroepiandrosterone Effects on HIV-1 Replication

> **NCT00065104** · PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 40 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** DHEA

## Key facts

- **NCT ID:** NCT00065104
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00065104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00065104, "Dehydroepiandrosterone Effects on HIV-1 Replication". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00065104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
